Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
29.91
+0.35 (1.18%)
At close: Dec 5, 2025, 4:00 PM EST
29.92
0.00 (0.02%)
After-hours: Dec 5, 2025, 5:01 PM EST
Centessa Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -242.7 | -235.76 | -151.09 | -216.21 | -381.9 | -10.66 | |
| Depreciation & Amortization | 0.31 | 0.34 | 0.31 | 0.13 | 0.03 | - | |
| Other Amortization | 1.48 | 0.6 | 0.5 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 220.45 | - | |
| Stock-Based Compensation | 31.35 | 33.55 | 29.39 | 24.97 | 14.85 | 0.34 | |
| Other Operating Activities | 37.07 | 37.05 | -20.63 | -6.78 | 16.43 | 0.24 | |
| Change in Accounts Payable | 1.51 | -4.59 | -2.72 | 6.35 | 3.8 | -0.05 | |
| Change in Other Net Operating Assets | -7.58 | 26.75 | -16.11 | -9.01 | -9.83 | -0.5 | |
| Operating Cash Flow | -180.81 | -142.06 | -160.34 | -200.55 | -136.16 | -10.63 | |
| Capital Expenditures | -0.36 | -0.03 | -0.17 | -1.14 | -0.19 | - | |
| Cash Acquisitions | - | - | - | - | 63.44 | - | |
| Investment in Securities | -175.04 | 31.3 | -126.84 | - | - | - | |
| Other Investing Activities | - | - | - | 0.21 | - | - | |
| Investing Cash Flow | -175.4 | 31.27 | -127 | -0.93 | 63.26 | - | |
| Long-Term Debt Issued | - | 109.34 | - | - | 73.93 | 1.36 | |
| Long-Term Debt Repaid | - | -110.1 | - | - | - | - | |
| Net Debt Issued (Repaid) | -0.76 | -0.76 | - | - | 73.93 | 1.36 | |
| Issuance of Common Stock | 18.45 | 370.83 | 21.12 | 0.72 | 344.92 | - | |
| Other Financing Activities | -5.71 | -5.32 | - | -0.26 | -0.3 | 0 | |
| Financing Cash Flow | 11.09 | 364.75 | 21.12 | 0.46 | 660.15 | 1.36 | |
| Foreign Exchange Rate Adjustments | 0.9 | 1.23 | 0.62 | -0.42 | 1.9 | -0.08 | |
| Net Cash Flow | -344.22 | 255.19 | -265.61 | -201.44 | 589.15 | -9.34 | |
| Free Cash Flow | -181.17 | -142.09 | -160.51 | -201.68 | -136.34 | -10.63 | |
| Free Cash Flow Margin | -1207.80% | - | -2342.20% | - | - | - | |
| Free Cash Flow Per Share | -1.36 | -1.24 | -1.67 | -2.16 | -1.81 | -0.71 | |
| Cash Interest Paid | 9.4 | 10.09 | 9.91 | 7.28 | 1.48 | - | |
| Cash Income Tax Paid | 1.17 | 0.08 | 2.94 | 1.3 | - | - | |
| Levered Free Cash Flow | -116.74 | -75.19 | -96.6 | -108.73 | -82.08 | - | |
| Unlevered Free Cash Flow | -110.66 | -68.88 | -90.41 | -104.18 | -80.49 | - | |
| Change in Working Capital | -6.07 | 22.16 | -18.83 | -2.66 | -6.03 | -0.55 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.